Finding the Right Dosage for the Esketamine Nasal Spray for Depression
When the FDA approved the fast-acting esketamine nasal spray Spravato™ in early 2019, it gave newfound hope to many people who struggle with treatment-resistant depression (TRD), or any major depressive disorder that hasn’t improved with traditional antidepressants. As a fully certified ketamine clinic, Bespoke Treatment is committed to providing innovative and individualized solutions for patients with TRD, including in-office esketamine treatments. Let’s explore …